Destiny Pharma
21 Podcast Episodes
1574: Vadim Alexandre discusses Spectral MD, Lunglife AI & Destiny Pharma
1574: Vadim Alexandre discusses Spectral MD, Lunglife AI & Destiny Pharma
Vadim Alexandre, Head of Healthcare at SP Angel discusses: Spectral MD #SMD Lunglife AI #LLAI Destiny Pharma #DEST
10 Aug 2023
•
26mins
1552: Alan Green talks about: Destiny Pharma, ECR, Acuity, First Class Metals & Truspine
1552: Alan Green talks about: Destiny Pharma, ECR, Acuity, First Class Metals & Truspine
Alan Green, CEO of Brand Communications talks about the following companies: Destiny Pharma #DEST ECR Minerals #ECR ... Read more
25 Jul 2023
•
30mins
Similar People
Craig Martin
Bill Brodie Good
Glen Goodman
Nick Lee
Arc Minerals
Dan Lane
Vadim Alexandre
Taylor Wimpey
Russ Mould
Mike Ralston
Cathal Friel
Charles Bray
Majid Shafiq
Graham Heath
John Meyer
1523: Vadim Alexandre on Asos, Boohoo, AO World, Deliveroo, Novacyt, YourGene & Destiny Pharma
1523: Vadim Alexandre on Asos, Boohoo, AO World, Deliveroo, Novacyt, YourGene & Destiny Pharma
Vadim Alexandre, Head of Healthcare at SP Angel covers some retail stocks and news from medical diagnostics & biotec... Read more
6 Jul 2023
•
27mins
1380: Neil Clark of Destiny Pharma: SPOR-COV® research reveals very exciting data and sets up potential royalty payments
1380: Neil Clark of Destiny Pharma: SPOR-COV® research reveals very exciting data and sets up potential royalty payments
Neil Clark, CEO of Destiny Pharma #DEST describes how SPOR-COV® showed positive results from testing in several COVID-19... Read more
2 May 2023
•
12mins
Most Popular
Elon Musk
Barack Obama
Bill Gates
LeBron James
Mark Cuban
Michelle Obama
Melinda Gates
Arnold Schwarzenegger
Kevin Hart
Terry Crews
Mike Tyson
1370: Vadim Alexandre discusses Polarean Imaging & Destiny Pharma
1370: Vadim Alexandre discusses Polarean Imaging & Destiny Pharma
Vadim Alexandre, Head of Healthcare at SP Angel talks about the following companies: Polarean Imaging #POLX & Destin... Read more
27 Apr 2023
•
26mins
1327: Neil Clark of Destiny Pharma: Our number one target is a deal on XF-73 this year
1327: Neil Clark of Destiny Pharma: Our number one target is a deal on XF-73 this year
Neil Clark, CEO & Shaun Claydon, CFO of Destiny Pharma #DEST discuss their final results & post period highlight... Read more
13 Apr 2023
•
16mins
1301: Neil Clark of Destiny Pharma discusses XF-73’s significant Phase 2 data published in a peer reviewed journal & potential upside
1301: Neil Clark of Destiny Pharma discusses XF-73’s significant Phase 2 data published in a peer reviewed journal & potential upside
Neil Clark, CEO of Destiny Pharma #DEST discusses XF-73’s Phase 2 data published in peer reviewed journal and the potent... Read more
24 Mar 2023
•
17mins
1211: Neil Clark & Shaun Claydon of Destiny Pharma: Collaboration for NTCD-M3 worth up to $570m plus royalties
1211: Neil Clark & Shaun Claydon of Destiny Pharma: Collaboration for NTCD-M3 worth up to $570m plus royalties
Neil Clark, CEO & Shaun Claydon CFO of Destiny Pharma #DEST discuss their exclusive collaboration and co-development... Read more
24 Feb 2023
•
8mins
883: Neil Clark & Shaun Claydon of Destiny Pharma: Significant progress in H1 will continue in 2022 & beyond
883: Neil Clark & Shaun Claydon of Destiny Pharma: Significant progress in H1 will continue in 2022 & beyond
Neil Clark CEO & Shaun Claydon, CFO of Destiny Pharma #DEST & reflect on the progress they have made on their la... Read more
8 Sep 2022
•
8mins
814: Neil Clark, CEO of Destiny Pharma, explains the significance of new data for NTCD-M3, its novel treatment for C. difficile infection
814: Neil Clark, CEO of Destiny Pharma, explains the significance of new data for NTCD-M3, its novel treatment for C. difficile infection
Destiny Pharma #DEST chief executive Neil Clark talks us through the publication of new data on NTCD-M3, its novel treat... Read more
26 Jul 2022
•
8mins
